Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | TYR | P14679 | 2/20 | 0.53 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.51 |
| ▸ | BID | P55957 | 3/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.51 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.51 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.51 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.51 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.51 |
| ▸ | PPARG | P37231 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | EP300 | Q09472 | 1/20 | 0.51 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.51 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.51 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.51 |
| ▸ | ELANE | P08246 | 2/20 | 0.47 |
| ▸ | CTSG | P08311 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574604 | 1.00 | ALOX5 (0.58) | ALOX5PTGS2TYRLIPGBID | |
| SCHEMBL573935 | 0.98 | ALOX5 (0.60) | ALOX5PTGS2TYRLIPGBID | |
| SCHEMBL574233 | 0.93 | ALOX5 (0.53) | ALOX5PTGS2TYRBIDMCL1 | |
| Parachlorophenol SCHEMBL8332607 | 0.91 | PTGS2 (0.50) | ALOX5PTGS2TYRLIPGBID | |
| SCHEMBL199708 | 0.87 | ALOX5 (0.68) | ALOX5PTGS2TYRLIPGBID | |
| SCHEMBL4960231 | 0.87 | ALOX5 (0.68) | ALOX5PTGS2TYRLIPGBID | |
| SCHEMBL11621072 | 0.87 | ALOX5 (0.68) | ALOX5PTGS2TYRLIPGBID | |
| SCHEMBL4959229 | 0.87 | ALOX5 (0.68) | ALOX5PTGS2TYRLIPGBID | |
| SCHEMBL11618297 | 0.87 | ALOX5 (0.68) | ALOX5PTGS2TYRLIPGBID | |
| SCHEMBL4962037 | 0.87 | ALOX5 (0.68) | ALOX5PTGS2TYRLIPGBID |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140135297-A1 | AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2014-05-15 | — | — | US | claimed |
| WO-2012170841-A1 | AN AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2012-12-13 | — | — | WO | claimed |
| EP-2313026-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | Castle Beach, L.L.C. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | Castle Beach, LLC (US) | 2010-02-18 | — | — | US | claimed |
| WO-2010019680-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | HOMOLA ANDREW M (US) | 2010-02-18 | — | — | WO | claimed |
| EP-1549731-B1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2008-12-17 | — | — | EP | claimed |
| EP-0805672-B1 | METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH | HOMOLA ANDREW M (US) | 2004-08-25 | — | — | EP | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| CN-119562805-A | Cannabinoid lipid premix | 费尔廷制药公司 | 2025-03-04 | — | — | CN | disclosed |
| EP-3653303-B1 | PIPETTE TIP RACK | BIOTIX INC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12201987-B2 | Pipette tip rack | BIOTIX, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-12082582-B2 | Synergistic preservative compositions, process for preparing the same and method of use thereof | ISP INVESTMENTS LLC (US) | 2024-09-10 | — | — | US | disclosed |
| CN-112153964-B | Oral tablets suitable for active pharmaceutical ingredient comprising non-directly compressible sugar alcohol particles | 费尔廷制药公司 | 2024-07-30 | — | — | CN | disclosed |
| US-5538715-A | DENTIFRICES WITH ANTIPLAQUE AGENTS FOR MOUTHS WITH HUMECTANTS, SILICA POLISHES AND BACTERICIDES | COLGATE PALMOLIVE COMPANY (US) | 1996-07-23 | — | — | US | disclosed |
| US-5288480-A | Antiplaque antibacterial oral composition | COLGATE-PALMOLIVE CO. (US) | 1994-02-22 | — | — | US | disclosed |
| US-5192530-A | Solubilizer, enhancing agent to aid retention, and delivery enhancement | COLGATE-PALMOLIVE COMPANY (US) | 1993-03-09 | — | — | US | disclosed |
| US-5178851-A | Dentifrices treatment with triclosan and carriers | COLGATE-PALMOLIVE COMPANY (US) | 1993-01-12 | — | — | US | disclosed |
| US-5080887-A | Polyphosphate, bactericide | COLGATE-PALMOLIVE COMPANY (US) | 1992-01-14 | — | — | US | disclosed |
| US-4894220-A | WATER AND ALCOHOL SOLVENTS, GLYCOL DERIVATIVES AND ESTERS SOLUTIONS | COLGATE-PALMOLIVE COMPANY (US) | 1990-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12082582-B2 | Synergistic preservative compositions, process for preparing the same and method of use thereof | HPD, EBP, TET1 | ALOX5 533/4885PTGS2 1449/4885TYR 1823/4885 |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | LIPA, MMP7, CTSA | ALOX5 716/4885PTGS2 342/4885TYR 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.